Myasthenia gravis constitutes chronic autoimmune condition that primarily affects the neuromuscular junction. This junction mediates the conveyance of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system incorrectly attacks these receptors, causing weakness and fatigue in the motor units. The indication